共 50 条
- [41] Devices and desires: industry fights toughening of medical device regulation in Europe (vol 347, f6204, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
- [42] Report shows rise in preventable errors during blood transfusion (vol 347, pg f4400, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
- [44] Bring me sunshine: EU drug companies make payments to doctors public (vol 347, f4342, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
- [45] Prioritising ward rounds would improve junior doctors' experience and patient care (vol 347, f7427, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
- [46] Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance (vol 347, f6544, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
- [47] GSK is to stop paying doctors to talk about its drugs and attend conferences (vol 347, f7579, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
- [48] India's health ministry bans pioglitazone, metamizole, and flupentixol-melitracen (vol 347, pg f4366, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
- [49] Red flags to screen for malignancy and fracture in patients with low back pain: systematic review (vol 347, f7095, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
- [50] Blanket ban on tobacco funded research risks missing out on good quality studies (vol 347, f6738, 2013) BMJ-BRITISH MEDICAL JOURNAL, 2013, 347